Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Gregersen VR"'
Autor:
Vega DM; Friends of Cancer Research, Washington, USA., Yee LM; National Cancer Institute, Bethesda, USA., McShane LM; National Cancer Institute, Bethesda, USA., Williams PM; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Chen L; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Vilimas T; Molecular Characterization Laboratory, Frederick National Lab for Cancer Research, Leidos Biomedical Research Inc., Frederick, USA., Fabrizio D; Foundation Medicine Inc., Cambridge, USA., Funari V; NeoGenomics Laboratories, Aliso Viejo, USA., Newberg J; Foundation Medicine Inc., Cambridge, USA., Bruce LK; NeoGenomics Laboratories, Aliso Viejo, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., Baden J; Bristol Myers Squibb Co., Princeton, USA., Carl Barrett J; AstraZeneca Pharmaceuticals LP, Waltham, USA., Beer P; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Butler M; LGC Clinical Diagnostics, Gaithersburg, USA., Cheng JH; ACT Genomics, Taipei, Taiwan., Conroy J; OmniSeq Inc., Buffalo, USA., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Eyring K; Intermountain Precision Genomics, St. George, USA., Garcia E; Brigham and Women's Hospital, Boston, USA., Green G; Bristol Myers Squibb Co., Princeton, USA., Gregersen VR; QIAGEN Inc, Aarhus, Denmark., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, USA., Keefer LA; Personal Genome Diagnostics, Baltimore, USA., Lasiter L; Friends of Cancer Research, Washington, USA., Lazar AJ; The University of Texas MD Anderson Cancer Center, Houston, USA., Li MC; National Cancer Institute, Bethesda, USA., MacConaill LE; Brigham and Women's Hospital, Boston, USA., Meier K; Illumina Inc, Clinical Genomics, San Diego, USA., Mellert H; Biodesix, Inc., Boulder, USA., Pabla S; OmniSeq Inc., Buffalo, USA., Pallavajjalla A; Johns Hopkins University, Baltimore, USA., Pestano G; Biodesix, Inc., Boulder, USA., Salgado R; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Samara R; QIAGEN Inc, Aarhus, Denmark., Sokol ES; Foundation Medicine Inc., Cambridge, USA., Stafford P; Caris Life Sciences Inc, Phoenix, USA., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Tom W; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, USA., Valkenburg KC; Personal Genome Diagnostics, Baltimore, USA., Wang XZ; EMD Serono Research and Development Institute, Inc., Billerica, USA., Weigman V; Q Squared Solutions, Durham, USA., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, USA., Xie Q; General Dynamics Information Technology, Inc., Columbia, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York, USA., Zhao C; Illumina Inc, Clinical Genomics, San Diego, USA., Zhao Y; National Cancer Institute, Bethesda, USA., Stewart MD; Friends of Cancer Research, Washington, USA. Electronic address: mstewart@focr.org., Allen J; Friends of Cancer Research, Washington, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1626-1636. Date of Electronic Publication: 2021 Oct 01.